Novartis Extends Triaminic Into Brand Name Void Left By J&J Tylenol Recall
This article was originally published in The Tan Sheet
Executive Summary
Novartis expedites a Triaminic line extension to take advantage of the branded product gap left by the recall of Johnson & Johnson's Children's Tylenol liquid OTCs
You may also be interested in...
Novartis Makes Room For OTC Division Head On Executive Committee
Novartis gives its OTC unit a direct line to the chief executive in an organizational realignment designed to strengthen and streamline the consumer businesses.
Novartis Makes Room For OTC Division Head On Executive Committee
Novartis gives its OTC unit a direct line to the chief executive in an organizational realignment designed to strengthen and streamline the consumer businesses.
Novartis Makes Room For OTC Division Head On Executive Committee
Novartis gives its OTC unit a direct line to the chief executive in an organizational realignment designed to strengthen and streamline the consumer businesses.